Suppr超能文献

角膜塑形术与 0.01%阿托品延缓近视儿童近视进展的临床疗效比较。

Comparison of the clinical efficacy of orthokeratology and 0.01% atropine for retardation of myopia progression in myopic children.

机构信息

Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China; Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Eye Institute of Shandong First Medical University, State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Jinan, Shandong, China; School of Ophthalmology, Shandong First Medical University, Jinan, Shandong, China.

Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Eye Institute of Shandong First Medical University, State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Jinan, Shandong, China.

出版信息

Cont Lens Anterior Eye. 2024 Feb;47(1):102094. doi: 10.1016/j.clae.2023.102094. Epub 2023 Nov 18.

Abstract

OBJECTIVE

To compare the clinical efficacy of orthokeratology (ortho-k) and 0.01% atropine for retardation of myopia progression in myopic children.

METHODS

This was a retrospective cohort study. A total of 282 patients, aged 8-17 years, were enrolled, including 100 children treated with ortho-k, 84 with 0.01% atropine, and 98 with single-vision spectacles. During the follow-up of 1 year, ortho-k wearers were examined at 1 day, 1 week, 1 month, 3 months after treatment, and thereafter every 3 months, while the others were examined every 3 months by measurements of uncorrected vision, intraocular pressure, refractive power, slit-lamp microscopy, corneal topography, and the lens fitting when necessary. The axial length was measured every 6 months.

RESULTS

Patients with ortho-k had stable uncorrected vision after 1 month of lens wear, all reaching 0 logMAR. The annual axial elongation was 0.23 ± 0.19 mm, 0.22 ± 0.20 mm, and 0.39 ± 0.27 mm in the ortho-k, atropine, and spectacle groups, respectively, with significant difference (F = 23.251, P = 0.000). The axial length was delayed to increase by 41.03% and 43.59% within a year in patients with ortho-k and atropine, respectively, as compared to patients with spectacles (F = 0.006, P = 0.936). The elongation was ≤ 0.3 mm in 69.0% and 66.7% of patients in the two groups, respectively, versus 38.8% in the spectacle group (χ = 17.251, P = 0.000). During the follow-up, the rate of corneal staining was 11.0% and 2.0% in the ortho-k and spectacle groups, respectively (χ = 8.076, P = 0.003). The use of atropine did not increase corneal staining, but the incidence of related photophobia was 4.8%. No other serious complications were observed.

CONCLUSION

Ortho-k lenses and 0.01% atropine can achieve similar efficacy of myopia retardation, which was significantly better than that obtained with single-vision spectacles, in myopic children. The risk of corneal staining after ortho-k wear may be slightly higher than that with spectacles, but could be well controlled.

摘要

目的

比较角膜塑形术(ortho-k)和 0.01%阿托品延缓近视儿童近视进展的临床疗效。

方法

这是一项回顾性队列研究。共纳入 282 名 8-17 岁的患者,其中 100 名接受 ortho-k 治疗,84 名接受 0.01%阿托品治疗,98 名接受单焦眼镜治疗。在 1 年的随访期间,接受 ortho-k 治疗的患者在治疗后 1 天、1 周、1 个月和 3 个月进行检查,此后每 3 个月检查一次,而其他患者每 3 个月进行一次非矫正视力、眼压、屈光力、裂隙灯显微镜、角膜地形图和必要时的镜片适配检查。每 6 个月测量一次眼轴长度。

结果

患者佩戴镜片 1 个月后,uncorrected vision 稳定,均达到 0 logMAR。眼轴每年延长 0.23±0.19mm、0.22±0.20mm 和 0.39±0.27mm,分别在 ortho-k、阿托品和眼镜组中,差异有统计学意义(F=23.251,P=0.000)。与戴眼镜的患者相比,佩戴 ortho-k 和阿托品的患者一年内眼轴延长分别延缓了 41.03%和 43.59%(F=0.006,P=0.936)。两组中有 69.0%和 66.7%的患者眼轴延长<0.3mm,而眼镜组只有 38.8%(χ²=17.251,P=0.000)。随访期间,角膜染色率在 ortho-k 组和眼镜组中分别为 11.0%和 2.0%(χ²=8.076,P=0.003)。使用阿托品不会增加角膜染色,但相关畏光的发生率为 4.8%。未观察到其他严重并发症。

结论

角膜塑形术和 0.01%阿托品均可达到类似的近视延缓效果,明显优于单焦眼镜,在近视儿童中。佩戴 ortho-k 后角膜染色的风险可能略高于佩戴眼镜,但可得到很好的控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验